Updates at Aagami:

  • New client win for Aagami - Netherlands HQ'd company with First-in-class phase-3-ready drug candidate for Post Operative Firbrosis (POF)
  • Aagami CEO attends a fruitful BIO Asia in Japan 14-15 March
  • Aagami CEO completes a successful business trip to Japan and Korea (March 10-29)
  • Aagami CEO to visit San Francisco, San Diego and Los Angeles, along with client CEO for high level strategic meetings for co-development partnerships (March 27 to April 7)